Provided by Tiger Trade Technology Pte. Ltd.

Oculis

10.14
+0.16001.60%
Post-market: 10.00-0.1400-1.38%19:52 EDT
Volume:411.95K
Turnover:4.12M
Market Cap:625.96M
PE:-5.91
High:10.43
Open:10.17
Low:9.67
Close:9.98
52wk High:34.48
52wk Low:9.65
Shares:61.73M
Float Shares:53.44M
Volume Ratio:1.87
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.35
PE(LYR):-4.24

Loading ...

Oculis Q2 2026 Results: Finance Gains Narrow the Net Loss Despite Higher Costs

TradingKey
·
Aug 07

Oculis Q2 Net Loss Narrows Despite Higher Expenses

Reuters
·
Aug 07

Oculis Reports Q2 2026 Financial Results and Provides Company Update

GlobeNewswire
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Lantheus (LNTH)

TIPRANKS
·
Aug 04

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

GlobeNewswire
·
Aug 03

Oculis to Acquire Mitie in £3.1 Billion Deal, Sending Target's Shares Soaring 40%

Deep News
·
Jul 21

Mitie Shares Soar on $4.2 Billion Takeover by OCS

Dow Jones
·
Jul 21

Mitie Halts £100m Share Buyback After Recommended OCS Takeover Offer

TIPRANKS
·
Jul 21

Village Farms Unveils Super Toast Bites, a New Line of Cannabis-Infused Gummies

GlobeNewswire
·
Jul 14

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jul 09

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

GlobeNewswire
·
Jul 02

Oculis Advances Privosegtor Into Phase 3 Optic Neuritis Trial: What Investors Should Watch

TIPRANKS
·
Jul 02

Nordic Shares Gain; Oculis Holding Tops Leaders

Dow Jones
·
Jul 01

Oculis Updates Investor Presentation, Emphasizing Late-Stage Neuro-Ophthalmic Pipeline and Cash Runway

TIPRANKS
·
Jun 26

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jun 16

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

GlobeNewswire
·
Jun 11

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

GlobeNewswire
·
Jun 11

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jun 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: Autolus Therapeutics (AUTL), Galmed Pharmaceuticals (GLMD) and Oculis Holding (OCS)

TIPRANKS
·
Jun 11

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jun 10